Skip to content
Screener

Charles River Laboratories CRL Unrecognized Tax Benefits Income Tax Penalties Accrued

Unrecognized Tax Benefits Income Tax Penalties Accrued at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$34.2M
Evercore logo
EvercoreEVR
$48K+269%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$0
Citigroup logo
CitigroupC
$2M+100%
Kestra Medical Technologies logo
Kestra Medical TechnologiesKMTS
$0
Citigroup logo
CitigroupC
$201M-15.2%

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$12.56B+70.1%
Enterprise value$15.36B+53.4%
P/S3.1×+1.3×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-6%
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued.

The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:21 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001100682-26-000118

For the three months ended June 27, 2026, the Company’s unrecognized tax benefits increased by $0.1 million to $158.2 million, primarily due to increases from acquisitions, offset by decreases from divestitures. For the three months ended June 27, 2026, the amount of unrecognized income tax benefits that would impact the effective tax rate increased by $0.1 million to $153.3 million for the same reasons discussed above. The accrued interest and penalties on unrecognized tax benefits were $32.7 million and $34.2 million, respectively, as of June 27, 2026.

Item 1. Financial Statements

FAQ

What is Charles River Laboratories's unrecognized tax benefits income tax penalties accrued?
Charles River Laboratories (CRL) reported unrecognized tax benefits income tax penalties accrued of $34.2M in Q2 2026.
What does unrecognized tax benefits income tax penalties accrued mean?
Unrecognized Tax Benefits Income Tax Penalties Accrued as reported by Charles River Laboratories International, Inc..

Ask your AI about Charles River Laboratories's unrecognized tax benefits income tax penalties accrued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude